24th October 2007
Did you hear this?
October 19, 2007 — Sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors, the US Food and Drug Administration warned healthcare professionals yesterday
The warning was based on 29 postmarketing cases that occurred in a strong temporal relationship to dosing with sildenafil (Viagra, Pfizer, Inc), tadalafil (Cialis, Lilly ICOS, LLC), and vardenafil (Levitra, Bayer Pharmaceuticals Corp), which were taken for the treatment of erectile dysfunction. Other cases were also reported during clinical trials
It is either hard.. or hard to hear!
October 19, 2007 — Sudden loss of hearing has been reported in patients taking phosphodiesterase 5 (PDE-5) inhibitors, the US Food and Drug Administration warned healthcare professionals yesterday
The warning was based on 29 postmarketing cases that occurred in a strong temporal relationship to dosing with sildenafil (Viagra, Pfizer, Inc), tadalafil (Cialis, Lilly ICOS, LLC), and vardenafil (Levitra, Bayer Pharmaceuticals Corp), which were taken for the treatment of erectile dysfunction. Other cases were also reported during clinical trials
It is either hard.. or hard to hear!
